Engineers Gate Manager LP Morphic Holding, Inc. Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$26.12 - $34.07 $273,058 - $356,167
10,454 New
10,454 $356,000
Q4 2023

Feb 14, 2024
BUY
$19.95 - $31.0 $97,016 - $150,753
4,863 Added 16.5%
34,328 $991,000
Q3 2023

Nov 14, 2023
BUY
$21.33 - $59.42 $628,488 - $1.75 Million
29,465 New
29,465 $675,000
Q1 2023

May 15, 2023
BUY
$26.01 - $48.69 $456,735 - $854,996
17,560 New
17,560 $660,000
Q3 2022

Nov 14, 2022
BUY
$22.23 - $33.37 $206,049 - $309,306
9,269 New
9,269 $262,000

Others Institutions Holding MORF

# of Institutions
8
Shares Held
4.7M
Call Options Held
0
Put Options Held
0
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email